PHARMACOLOGY OF MERCURY-COMPOUNDS

被引:384
作者
CLARKSON, TW
机构
来源
ANNUAL REVIEW OF PHARMACOLOGY | 1972年 / 12卷
关键词
D O I
10.1146/annurev.pa.12.040172.002111
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:375 / +
相关论文
共 146 条
[21]  
CLARKSON THOMAS, 1964, HEALTH PHYS, V10, P1115, DOI 10.1097/00004032-196412000-00032
[22]   STUDIES ON BINDING OF MERCURY IN TISSUE HOMOGENATES [J].
CLARKSON, TW ;
MAGOS, L .
BIOCHEMICAL JOURNAL, 1966, 99 (01) :62-&
[23]  
CLARKSON TW, 1966, FED PROC, V25, P197
[24]   MECHANISM OF ACTION OF MERCURIAL DIURETICS IN RATS RENAL METABOLISM OF P-CHLOROMERCURIBENZOATE AND ITS EFFECTS ON URINARY EXCRETION [J].
CLARKSON, TW ;
GREENWOOD, M .
BRITISH JOURNAL OF PHARMACOLOGY AND CHEMOTHERAPY, 1966, 26 (01) :50-+
[25]  
CLARKSON TW, 1965, BRIT J PHARM CHEMOTH, V24, P1
[26]   EFFECT OF 2,4-DINITROPHENOL AND OTHER METABOLIC INHIBITORS ON RENAL DEPOSITION AND EXCRETION OF MERCURY [J].
CLARKSON, TW ;
MAGOS, L .
BIOCHEMICAL PHARMACOLOGY, 1970, 19 (12) :3029-&
[27]  
CLARKSON TW, 1961, AEP592 U ROCH REP
[28]  
CLARKSON TW, 1971, FOOD COSMETOL TOXICO, V19, P229
[29]  
CLARKSON TW, 1971, PHARMACODYNAMICS MER
[30]  
CLARKSON TW, 1970, INT C ENVIRONMENTAL